FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals [0.03%]
美国FDA重新考虑人体首次放射性药物PET的人体辐射剂量规定细则
Marianna Dakanali,Steven S Zigler,Sally W Schwarz et al.
Marianna Dakanali et al.
FDA Approval of 18F-Flurpiridaz Is for PET: Stepping into a New Area of Myocardial Perfusion Imaging? [0.03%]
美国 FDA 批准 18F-Flurpiridaz 用于心肌灌注显像的正电子发射断层扫描(PET)：迈向心肌灌注显像新领域的一步？
Thomas H Schindler,Timothy M Bateman,Daniel S Berman et al.
Thomas H Schindler et al.
Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer [0.03%]
靶向纤维连接蛋白(extra domain A)以提高三阴性乳腺癌的非侵入式检测率
Justin S Hachey,Tara D Viray,Mattia Matasci et al.
Justin S Hachey et al.
Triple-negative breast cancer (TNBC) lags behind other breast cancer types in targeted therapeutic and diagnostic imaging agent development, largely due to high disease heterogeneity. Noninvasive imaging is essential for diagnosing and stag...
Is Long-Axial-Field-of-View PET/CT Cost-Effective? An International Health-Economic Analysis [0.03%]
长轴大视野PET/CT是否具有成本效益？国际卫生经济分析
Ian Alberts,Stuart More,Karen Knapp et al.
Ian Alberts et al.
Our aim is to assess the cost-effectiveness of long-axial-field-of-view (LAFOV) versus short-axial FOV (SAFOV) PET/CT systems using international data. Methods: Our model compares equipment and operational costs for a PET/CT center and inve...
[18F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies [0.03%]
[18F]氟罗佐拉Tau-PET用于疑似四重复tau病患者的帕金森氏症鉴别诊断
Joachim Brumberg,Nils Schröter,Ganna Blazhenets et al.
Joachim Brumberg et al.
The second-generation tau radioligand [18F]florzolotau is a promising biomarker for 4-repeat (4R) tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), which are difficult to disentangle clinically. P...
Semiquantitative PET Parameters Refine Prognosis in CAR T-Treated Lymphoma After 1 and 3 Months: A Prospective Single-Center Study [0.03%]
半定量PET参数可改善CAR-T治疗后淋巴瘤患者1个月和3个月预后的预测：一项前瞻性单中心研究
Andrea Farolfi,Beatrice Casadei,Claudio Malizia et al.
Andrea Farolfi et al.
Chimeric antigen receptor T-cell (CAR T) therapy has shown remarkable efficacy in treating relapsed or refractory large B-cell lymphoma. However, for nearly half of these patients, the therapy eventually does not achieve durable remission. ...
Emmanuel Deshayes,Ioannis Karfis,Lore Santoro et al.
Emmanuel Deshayes et al.
Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT [0.03%]
前列腺癌因PSMA PET/CT检测到的孤立性睾丸转移复发
Mateus de Oliveira Taveira,Ali Aria Razmaria,Heiko Schoder et al.
Mateus de Oliveira Taveira et al.
Prostate cancer is the most common solid malignancy to metastasize to the testicles, although testicular metastases remain rare and are often discovered only postmortem. Methods: Retrospective analysis of 95 68Ga-prostate-specific membrane ...
Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX-Based Attenuation Correction Using a Long-Axial-Field-of-View PET/CT Scanner [0.03%]
基于CT和LSO-TX衰减校正的超低剂量PET扫描方案在长轴视野PET/CT上的可行性研究
Hasan Sari,Mohammadreza Teimoorisichani,Marco Viscione et al.
Hasan Sari et al.
Long-axial-field-of-view (LAFOV) PET scanners enable substantial reduction in injected radiotracer activity while maintaining clinically feasible scan times. Whole-body CT scans performed for PET attenuation correction can significantly add...
[68Ga]Ga-RAYZ-8009: A Peptide PET Tracer for Targeting HCC in Humans [0.03%]
[68Ga]Ga-RAYZ-8009：一种靶向人类肝细胞癌的肽PET示踪剂
Yue Zhang,Jiangtao Yue,Xuhong Yang et al.
Yue Zhang et al.